Genomatica Stock

Genomatica manufactures sustainable chemicals from renewable feedstocks.

Sign up today and learn more about Genomatica Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Genomatica Stock

Genomatica is a widely-recognized leader in bioengineering and aims to lead a transition to more sustainable materials. It develops bio-based process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability and performance. Genomatica has earned widespread acclaim for its technology; has commercialized processes for the chemical butanediol (for biodegradable plastics and apparel) and for butylene glycol (cosmetics and personal care); and is working on bio-nylon. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award for its Brontide(TM) butylene glycol.

Funding History

May 2002$4.0M
July 2007$20.0M
April 2010$15.0M
March 2011$45.0M
August 2012$46.4M
August 2012$41.5M
March 2014$6.8M
October 2018$90.0M
July 2021$118M


Co-Founder, President & CEO

Christophe Schilling

Executive Vice President, Process Technology

Jeff Lievense

Vice President, Operations & Technology Transfer

Joseph P. Kuterbach

Vice President, Research & Development

Nelson Barton

Executive Chairman and Chief Business Development Officer

Bill Baum

Senior Vice President, Finance and CFO

Tom McDonald

Vice President, People & Culture

Amy Buono

Board of Directors

Thomas Huot

Board of Directors

Just Janz

Board of Directors

Warren Clark

Board of Directors

Josh Green


Steve Weiss

Senior Research Scientist, Strain Engineering

Brandon Chen

Member of Board of Directors

Steve Jurvetson

executive chairman

William H. Baum

Board of Directors

Leighton Read

Senior Vice President, Specialty Products

Damien A. Perriman

Chief Operating Officer

David Muldoon


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: